再鼎医药启动2亿美元美国存托股份发售
财中社11月14日电再鼎医药（09688/ZLAB）发布公告，宣布将启动规模为2亿美元的美国存托股份的后续发售。此次发售将以每个美国存托股份代表十股普通股的形式进行，面值为0.000006美元。公司计划授予承销商30日的选择权，以公开发售价减去承销折扣和佣金，额外购买最多15%的公开发售中出售的美国存托股份。所得款项净额将用于一般企业用途。
本次发售将根据S-3ASR表格的注册登记声明进行，该声明将于2024年4月19日向SEC提交后自动生效。公告中指出，发售受市场和其他条件的限制，无法保证发售会否完成或何时完成。公司提醒股东及潜在投资者在买卖公司证券时务请审慎行事。
（文章来源：财中社）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10